- Home
- SBFM vs ACON Comparison
SBFM vs ACON Comparison
Compare SBFM & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBFM | ACON |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 7.4M |
| IPO Year | 2008 | 2022 |
Fundamental Metrics
Financial Performance| Metric | SBFM | ACON |
|---|---|---|
| Price | $1.13 | $2.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | $7.00 |
| AVG Volume (30 Days) | ★ 696.5K | 60.4K |
| Earning Date | 04-03-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 99.82 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $36,305,891.00 | $75,730.00 |
| Revenue This Year | $40.47 | $87.22 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 4.11 | ★ 65.62 |
| 52 Week Low | $0.25 | $1.95 |
| 52 Week High | $3.05 | $12.03 |
Technical Indicators
Market Signals| Indicator | SBFM | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 37.36 | 41.47 |
| Support Level | $1.12 | $1.95 |
| Resistance Level | $1.24 | $2.50 |
| Average True Range (ATR) | 0.10 | 0.19 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 38.33 | 5.26 |
Price Performance
Historical ComparisonAbout SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.